Back To TopGet Opthea Updates
Bruno Gagnon

Bruno Gagnon

Bruno joined Opthea in July 2022 and leads Global Clinical Operations. Bruno is former Sr. Vice President of Development Operations at Eidos Therapeutics, a BridgeBio company in San Francisco, CA. He also served as Vice President of Clinical Operations at BioMarin...
Fang Li

Fang Li

Dr. Li is an accomplished regulatory affairs professional with over three decades of experience in pharmaceutical development and regulatory affairs. She has held leadership positions at Novartis, Alcon, and Bausch & Lomb, where her contributions encompass health...
Julie Clark

Julie Clark

Dr. Clark brings more than 15 years of experience in ophthalmology and clinical development, encompassing expertise in early and late-stage development programs, regulatory submissions, and approvals. Her impactful contributions contributed to the approval and...
Judith Robertson

Judith Robertson

Judith Robertson was appointed Chief Commercial Officer of Opthea in January 2022. Ms Robertson was most recently Chief Commercial Officer of Eleusis Ltd and serves on the board of Durect Corporation, a Nasdaq listed company developing therapies for acute organ injury...
Megan Baldwin

Megan Baldwin

Dr Megan Baldwin is currently Founder, Chief Innovation Officer and Executive Director of Opthea, having led the company as CEO and Managing Director from February 2014 to October 2023.  She brings has over 25 years of experience focusing on angiogenesis and...
Peter Lang

Peter Lang

Mr. Lang comes to Opthea with over 25 years of experience delivering strategic, operational, and financial solutions, with deep expertise in the healthcare and biopharmaceutical sectors. He has held leadership roles at biopharmaceutical companies and well-recognized...